Jersey, Channel Islands | N/A | ||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||
70 St. Mary Axe London EC3A 8BE United Kingdom (Address of principal executive offices) | Not applicable (Zip Code) |
Title of each class | Trading Symbol(s) | Name of exchange on which registered | ||||||
Ordinary Shares, no par value | CLVT | New York Stock Exchange | ||||||
5.25% Series A Mandatory Convertible Preferred Shares, no par value | CLVT PR A | New York Stock Exchange |
Large accelerated filer | ☒ | Accelerated filer | ☐ | |||||||||||||||||
Non-accelerated filer | ☐ | Smaller reporting company | ☐ | |||||||||||||||||
Emerging growth company | ☐ |
Page | |||||
June 30, 2022 | December 31, 2021 | ||||||||||
Assets | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 359.7 | $ | 430.9 | |||||||
Restricted cash | 13.2 | 156.7 | |||||||||
Accounts receivable, net | 812.4 | 906.4 | |||||||||
Prepaid expenses | 102.1 | 76.6 | |||||||||
Other current assets | 72.8 | 66.6 | |||||||||
Total current assets | 1,360.2 | 1,637.2 | |||||||||
Property and equipment, net | 76.8 | 83.8 | |||||||||
Other intangible assets, net | 9,697.3 | 10,392.4 | |||||||||
Goodwill | 7,533.7 | 7,904.9 | |||||||||
Other non-current assets | 71.3 | 50.8 | |||||||||
Deferred income taxes | 28.2 | 27.9 | |||||||||
Operating lease right-of-use assets | 68.6 | 86.0 | |||||||||
Total Assets | $ | 18,836.1 | $ | 20,183.0 | |||||||
Liabilities and Shareholders’ Equity | |||||||||||
Current liabilities: | |||||||||||
Accounts payable | $ | 116.7 | $ | 129.2 | |||||||
Accrued expenses and other current liabilities | 501.1 | 679.6 | |||||||||
Current portion of deferred revenues | 956.7 | 1,030.4 | |||||||||
Current portion of operating lease liability | 29.9 | 32.2 | |||||||||
Current portion of long-term debt | 57.1 | 30.6 | |||||||||
Total current liabilities | 1,661.5 | 1,902.0 | |||||||||
Long-term debt | 5,421.5 | 5,456.3 | |||||||||
Warrant liabilities | 78.4 | 227.8 | |||||||||
Non-current portion of deferred revenues | 50.3 | 54.2 | |||||||||
Other non-current liabilities | 136.7 | 142.7 | |||||||||
Deferred income taxes | 366.0 | 380.1 | |||||||||
Operating lease liabilities | 81.0 | 94.0 | |||||||||
Total liabilities | 7,795.4 | 8,257.1 | |||||||||
Commitments and contingencies | |||||||||||
Shareholders’ equity: | |||||||||||
Preferred Shares, no par value; 14,375,000 shares authorized; 5.25% Mandatory Convertible Preferred Shares, Series A, 14,375,000 shares issued and outstanding as of both June 30, 2022 and December 31, 2021 | 1,392.6 | 1,392.6 | |||||||||
Ordinary Shares, no par value; unlimited shares authorized at June 30, 2022 and December 31, 2021; 673,821,721 and 683,139,210 shares issued, and 673,316,307 and 683,139,210 shares outstanding at June 30, 2022 and December 31, 2021, respectively | 11,700.9 | 11,827.9 | |||||||||
Treasury shares, at cost; 505,414 and 547,136 shares as of June 30, 2022 and December 31, 2021, respectively | (15.6) | (16.9) | |||||||||
Accumulated other comprehensive (loss) income | (519.2) | 326.7 | |||||||||
Accumulated deficit | (1,518.0) | (1,604.4) | |||||||||
Total shareholders’ equity | 11,040.7 | 11,925.9 | |||||||||
Total Liabilities and Shareholders’ Equity | $ | 18,836.1 | $ | 20,183.0 |
Three Months Ended June 30, | |||||||||||
2022 | 2021 | ||||||||||
Revenues, net | $ | 686.6 | $ | 445.7 | |||||||
Operating expenses: | |||||||||||
Cost of revenues | 244.1 | 149.7 | |||||||||
Selling, general and administrative costs | 186.1 | 179.7 | |||||||||
Depreciation and amortization | 175.6 | 130.3 | |||||||||
Restructuring and impairment | 19.2 | 50.7 | |||||||||
Other operating (income) expense, net | (24.6) | (0.9) | |||||||||
Total operating expenses | 600.4 | 509.5 | |||||||||
Income (loss) from operations | 86.2 | (63.8) | |||||||||
Mark to market (gain) loss on financial instruments | (49.0) | 21.0 | |||||||||
Income (loss) before interest expense and income taxes | 135.2 | (84.8) | |||||||||
Interest expense and amortization of debt discount, net | 62.3 | 38.5 | |||||||||
Income (loss) before income taxes | 72.9 | (123.3) | |||||||||
Provision for income taxes | 10.5 | 8.2 | |||||||||
Net income (loss) | 62.4 | (131.5) | |||||||||
Dividends on preferred shares | 18.7 | — | |||||||||
Net income (loss) attributable to ordinary shares | $ | 43.7 | $ | (131.5) | |||||||
Per share: | |||||||||||
Basic | $ | 0.06 | $ | (0.22) | |||||||
Diluted | $ | — | $ | (0.22) | |||||||
Weighted average shares used to compute earnings per share: | |||||||||||
Basic | 674,256,004 | 611,093,882 | |||||||||
Diluted | 678,372,059 | 611,093,882 |
Six Months Ended June 30, | |||||||||||
2022 | 2021 | ||||||||||
Revenues, net | $ | 1,348.8 | $ | 874.1 | |||||||
Operating expenses: | |||||||||||
Cost of revenues | 493.3 | 297.6 | |||||||||
Selling, general and administrative costs | 379.8 | 314.0 | |||||||||
Depreciation and amortization | 352.0 | 261.9 | |||||||||
Restructuring and impairment | 30.9 | 118.6 | |||||||||
Other operating (income) expense, net | (38.3) | 15.3 | |||||||||
Total operating expenses | 1,217.7 | 1,007.4 | |||||||||
Income (loss) from operations | 131.1 | (133.3) | |||||||||
Mark to market gain on financial instruments | (149.4) | (30.2) | |||||||||
Income (loss) before interest expense and income taxes | 280.5 | (103.1) | |||||||||
Interest expense and amortization of debt discount, net | 121.8 | 75.9 | |||||||||
Income (loss) before income taxes | 158.7 | (179.0) | |||||||||
Provision for income taxes | 26.8 | 8.5 | |||||||||
Net income (loss) | 131.9 | (187.5) | |||||||||
Dividends on preferred shares | 37.4 | — | |||||||||
Net income (loss) attributable to ordinary shares | $ | 94.5 | $ | (187.5) | |||||||
Per share: | |||||||||||
Basic | $ | 0.14 | $ | (0.31) | |||||||
Diluted | $ | (0.07) | $ | (0.35) | |||||||
Weighted average shares used to compute earnings per share: | |||||||||||
Basic | 678,348,003 | 606,795,733 | |||||||||
Diluted | 683,167,949 | 617,138,407 |
Three Months Ended June 30, | |||||||||||
2022 | 2021 | ||||||||||
Net income (loss) | $ | 62.4 | $ | (131.5) | |||||||
Other comprehensive income (loss), net of tax: | |||||||||||
Interest rate swaps | 3.8 | 0.2 | |||||||||
Defined benefit pension plans | 0.1 | — | |||||||||
Foreign currency translation adjustment | (626.6) | 46.9 | |||||||||
Total other comprehensive (loss) income, net of tax | (622.7) | 47.1 | |||||||||
Comprehensive loss | $ | (560.3) | $ | (84.4) |
Six Months Ended June 30, | |||||||||||
2022 | 2021 | ||||||||||
Net income (loss) | $ | 131.9 | $ | (187.5) | |||||||
Other comprehensive income (loss), net of tax: | |||||||||||
Interest rate swaps | 15.7 | 1.5 | |||||||||
Defined benefit pension plans | 0.1 | — | |||||||||
Foreign currency translation adjustment | (861.7) | 65.2 | |||||||||
Total other comprehensive (loss) income, net of tax | (845.9) | 66.7 | |||||||||
Comprehensive loss | $ | (714.0) | $ | (120.8) |
Ordinary Shares | Preferred Shares | Treasury Shares | Accumulated Other Comprehensive Income (Loss) | Accumulated Deficit | Total Shareholders’ Equity | ||||||||||||||||||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Shares | Amount | ||||||||||||||||||||||||||||||||||||||||||||||||
Balance at December 31, 2021 | 683.1 | $ | 11,827.9 | 14.4 | $ | 1,392.6 | 0.5 | $ | (16.9) | $ | 326.7 | $ | (1,604.4) | $ | 11,925.9 | ||||||||||||||||||||||||||||||||||||||
Reclassification of EBT Shares | (0.5) | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||
Exercise of stock options | 0.2 | 0.4 | — | — | — | — | — | — | 0.4 | ||||||||||||||||||||||||||||||||||||||||||||
Vesting of restricted stock units | 0.7 | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||
Shares returned to the Company for net share settlements | (0.4) | (5.4) | — | — | — | — | — | — | (5.4) | ||||||||||||||||||||||||||||||||||||||||||||
Share-based award activity | — | 26.9 | — | — | — | — | — | — | 26.9 | ||||||||||||||||||||||||||||||||||||||||||||
Repurchases of ordinary shares | (4.1) | — | — | — | 4.1 | (66.4) | — | — | (66.4) | ||||||||||||||||||||||||||||||||||||||||||||
Retirement of treasury shares | — | (34.8) | — | — | (2.1) | 33.3 | — | 1.5 | — | ||||||||||||||||||||||||||||||||||||||||||||
Sale of treasury shares | — | — | — | — | — | 1.3 | — | (0.7) | 0.6 | ||||||||||||||||||||||||||||||||||||||||||||
Dividends to preferred shareholders | — | — | — | — | — | — | — | (18.7) | (18.7) | ||||||||||||||||||||||||||||||||||||||||||||
Net income | — | — | — | — | — | — | — | 69.5 | 69.5 | ||||||||||||||||||||||||||||||||||||||||||||
Other comprehensive loss | — | — | — | — | — | — | (223.2) | — | (223.2) | ||||||||||||||||||||||||||||||||||||||||||||
Balance at March 31, 2022 | 679.0 | $ | 11,815.0 | 14.4 | $ | 1,392.6 | 2.5 | $ | (48.7) | $ | 103.5 | $ | (1,552.8) | $ | 11,709.6 | ||||||||||||||||||||||||||||||||||||||
Exercise of stock options | — | 0.1 | — | — | — | — | — | — | 0.1 | ||||||||||||||||||||||||||||||||||||||||||||
Vesting of restricted stock units | 1.3 | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||
Shares returned to the Company for net share settlements | (0.4) | (5.3) | — | — | — | — | — | — | (5.3) | ||||||||||||||||||||||||||||||||||||||||||||
Share-based award activity | — | 23.6 | — | — | — | — | — | — | 23.6 | ||||||||||||||||||||||||||||||||||||||||||||
Repurchases of ordinary shares | (6.6) | — | — | — | 6.6 | (108.6) | — | — | (108.6) | ||||||||||||||||||||||||||||||||||||||||||||
Retirement of treasury shares | — | (132.5) | — | — | (8.6) | 141.7 | — | (9.2) | — | ||||||||||||||||||||||||||||||||||||||||||||
Sale of treasury shares | — | — | — | — | — | — | — | 0.3 | 0.3 | ||||||||||||||||||||||||||||||||||||||||||||
Dividends to preferred shareholders | — | — | — | — | — | — | — | (18.7) | (18.7) | ||||||||||||||||||||||||||||||||||||||||||||
Net income | — | — | — | — | — | — | — | 62.4 | 62.4 | ||||||||||||||||||||||||||||||||||||||||||||
Other comprehensive income | — | — | — | — | — | — | (622.7) | — | (622.7) | ||||||||||||||||||||||||||||||||||||||||||||
Balance at June 30, 2022 | 673.3 | $ | 11,700.9 | 14.4 | $ | 1,392.6 | 0.5 | $ | (15.6) | $ | (519.2) | $ | (1,518.0) | $ | 11,040.7 |
Ordinary Shares | Preferred Shares | Treasury Shares | Accumulated Other Comprehensive Income (Loss) | Accumulated Deficit | Total Shareholders’ Equity | ||||||||||||||||||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Shares | Amount | ||||||||||||||||||||||||||||||||||||||||||||||||
Balance at December 31, 2020 | 606.3 | $ | 9,989.2 | — | $ | — | 6.3 | $ | (196.0) | $ | 492.4 | $ | (1,250.8) | $ | 9,034.8 | ||||||||||||||||||||||||||||||||||||||
Exercise of Private Placement Warrants | 0.2 | 3.6 | — | — | — | — | — | — | 3.6 | ||||||||||||||||||||||||||||||||||||||||||||
Exercise of stock options | 0.8 | 5.1 | — | — | — | — | — | — | 5.1 | ||||||||||||||||||||||||||||||||||||||||||||
Shares returned to the Company for net share settlements | (0.4) | (4.5) | — | — | — | — | — | — | (4.5) | ||||||||||||||||||||||||||||||||||||||||||||
Issuance of ordinary shares, net | 4.4 | 105.5 | — | — | — | — | — | — | 105.5 | ||||||||||||||||||||||||||||||||||||||||||||
Share-based award activity | — | 10.5 | — | — | — | — | — | — | 10.5 | ||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) | — | — | — | — | — | — | — | (56.0) | (56.0) | ||||||||||||||||||||||||||||||||||||||||||||
Other comprehensive income | — | — | — | — | — | — | 19.6 | — | 19.6 | ||||||||||||||||||||||||||||||||||||||||||||
Balance at March 31, 2021 | 611.3 | $ | 10,109.4 | — | $ | — | 6.3 | $ | (196.0) | $ | 512.0 | $ | (1,306.8) | $ | 9,118.6 | ||||||||||||||||||||||||||||||||||||||
Exercise of stock options | 1.6 | 9.7 | — | — | — | — | — | — | 9.7 | ||||||||||||||||||||||||||||||||||||||||||||
Vesting of restricted stock units | 0.5 | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||
Shares returned to the Company for net share settlements | (0.8) | (17.2) | — | — | — | — | — | — | (17.2) | ||||||||||||||||||||||||||||||||||||||||||||
Issuance of ordinary shares, net | 206.0 | 5,780.9 | — | — | — | — | — | — | 5,780.9 | ||||||||||||||||||||||||||||||||||||||||||||
Share-based award activity | — | 12.9 | — | — | — | — | — | — | 12.9 | ||||||||||||||||||||||||||||||||||||||||||||
Repurchase of ordinary shares | — | — | — | — | (177.2) | (5,052.2) | — | — | (5,052.2) | ||||||||||||||||||||||||||||||||||||||||||||
Retirement of treasury shares | (177.2) | (5,052.2) | — | — | 177.2 | 5,052.2 | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||
Issuance of preferred shares, net | — | — | 14.4 | 1,393.2 | — | — | — | — | 1,393.2 | ||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) | — | — | — | — | — | — | — | (131.5) | (131.5) | ||||||||||||||||||||||||||||||||||||||||||||
Other comprehensive income | — | — | — | — | — | — | 47.1 | — | 47.1 | ||||||||||||||||||||||||||||||||||||||||||||
Balance at June 30, 2021 | 641.4 | $ | 10,843.5 | 14.4 | $ | 1,393.2 | 6.3 | $ | (196.0) | $ | 559.1 | $ | (1,438.3) | $ | 11,161.5 | ||||||||||||||||||||||||||||||||||||||
Six Months Ended June 30, | |||||||||||
2022 | 2021 | ||||||||||
Cash Flows From Operating Activities | |||||||||||
Net income (loss) | $ | 131.9 | $ | (187.5) | |||||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||||||||
Depreciation and amortization | 352.0 | 261.9 | |||||||||
Deferred income taxes | (0.9) | (0.6) | |||||||||
Share-based compensation | 47.2 | 18.8 | |||||||||
Restructuring and impairment | (1.0) | 69.6 | |||||||||
Loss (gain) on foreign currency forward contracts | 5.7 | (1.9) | |||||||||
Mark to market adjustment on contingent shares | — | (25.1) | |||||||||
Mark to market gain on financial instruments | (149.4) | (30.2) | |||||||||
Amortization of debt issuance costs | 7.6 | 4.7 | |||||||||
Other operating activities | (39.3) | 9.0 | |||||||||
Changes in operating assets and liabilities: | |||||||||||
Accounts receivable | 53.8 | 108.7 | |||||||||
Prepaid expenses | (26.9) | (7.9) | |||||||||
Other assets | (24.8) | 51.9 | |||||||||
Accounts payable | (8.8) | 5.9 | |||||||||
Accrued expenses and other current liabilities | (150.3) | 49.6 | |||||||||
Deferred revenues | (29.5) | (38.3) | |||||||||
Operating lease right of use assets | 14.5 | 11.8 | |||||||||
Operating lease liabilities | (11.1) | (40.3) | |||||||||
Other liabilities | (6.1) | 1.6 | |||||||||
Net cash provided by operating activities | 164.6 | 261.7 | |||||||||
Cash Flows From Investing Activities | |||||||||||
Capital expenditures | (89.1) | (62.0) | |||||||||
Acquisitions, net of cash acquired | (9.3) | 0.4 | |||||||||
Acquisition of cost method investment | (5.0) | — | |||||||||
Net cash used in investing activities | (103.4) | (61.6) | |||||||||
Cash Flows From Financing Activities | |||||||||||
Proceeds from issuance of debt | — | 2,000.0 | |||||||||
Principal payments on term loan | (14.3) | (14.3) | |||||||||
Payment of debt issuance costs and discounts | (2.1) | (4.4) | |||||||||
Proceeds from issuance of preferred shares | — | 1,393.2 | |||||||||
Proceeds from issuance of ordinary shares | — | 728.8 | |||||||||
Proceeds from issuance of treasury shares | 0.9 | — | |||||||||
Repurchases of ordinary shares | (175.0) | — | |||||||||
Cash dividends on preferred shares | (37.7) | — | |||||||||
Proceeds from stock options exercised | 0.5 | 14.8 | |||||||||
Payments related to finance lease | (1.0) | — | |||||||||
Payments related to tax withholding for stock-based compensation | (10.7) | (21.7) | |||||||||
Net cash (used in) provided by financing activities | (239.4) | 4,096.4 | |||||||||
Effects of exchange rates | (36.5) | 5.0 | |||||||||
Net (decrease) increase in cash and cash equivalents | $ | (71.2) | $ | 2,301.9 | |||||||
Net (decrease) increase in restricted cash | (143.5) | 1,999.6 | |||||||||
Net (decrease) increase in cash and cash equivalents, and restricted cash | (214.7) | 4,301.5 |
Six Months Ended June 30, | |||||||||||
2022 | 2021 | ||||||||||
Beginning of period: | |||||||||||
Cash and cash equivalents | $ | 430.9 | $ | 257.7 | |||||||
Restricted cash | 156.7 | 14.7 | |||||||||
Total cash and cash equivalents, and restricted cash, beginning of period | 587.6 | 272.4 | |||||||||
End of period: | |||||||||||
Cash and cash equivalents | 359.7 | 2,559.6 | |||||||||
Restricted cash | 13.2 | 2,014.3 | |||||||||
Total cash and cash equivalents, and restricted cash, end of period | $ | 372.9 | $ | 4,573.9 | |||||||
Supplemental Cash Flow Information: | |||||||||||
Cash paid for interest | $ | 113.4 | $ | 69.7 | |||||||
Cash paid for income tax | $ | 23.7 | $ | 12.6 | |||||||
Capital expenditures included in accounts payable | $ | 23.8 | $ | 3.8 | |||||||
Non-Cash Financing Activities: | |||||||||||
Shares issued to Capri Acquisition Topco Limited | — | 5,052.2 | |||||||||
Retirement of treasury shares | (175.0) | (5,052.2) | |||||||||
Shares issued as contingent stock consideration associated with the DRG acquisition | — | 61.6 | |||||||||
Shares issued as contingent stock consideration associated with the CPA Global acquisition | — | 43.9 | |||||||||
Dividends accrued on our 5.25% Series A Mandatory Convertible Preferred Shares | 6.2 | — | |||||||||
Total Non-Cash Financing Activities | $ | (168.8) | $ | 105.5 | |||||||
Issuance of 46.9 million shares(1) | $ | 1,094.9 | ||||||
Cash consideration(2) | 3,959.9 | |||||||
Total purchase price | 5,054.8 | |||||||
Cash acquired(3) | (52.5) | |||||||
Total purchase price, net of cash acquired | $ | 5,002.3 | ||||||
(1) Based on the Company’s closing share price of $23.34 on November 30, 2021. | ||||||||
(2) Total cash consideration of $3,959.9 includes a base cash consideration of $3,988.0, less working capital adjustments of $31.7, less closing indebtedness adjustments of $36.6, plus closing cash consideration of $40.2. | ||||||||
(3) Cash acquired includes $52.5 of total cash acquired, less $2.0 of restricted cash acquired. |
Original Purchase Price Allocation | Measurement Period Adjustments | Updated Purchase Price Allocation | |||||||||||||||
Accounts receivable | $ | 113.5 | $ | 1.2 | $ | 114.7 | |||||||||||
Prepaid expenses | 22.3 | 0.9 | 23.2 | ||||||||||||||
Other current assets | 23.7 | — | 23.7 | ||||||||||||||
Property and equipment, net | 62.3 | 2.9 | 65.2 | ||||||||||||||
Other intangible assets(1) | 3,534.7 | (1.0) | 3,533.7 | ||||||||||||||
Other non-current assets | 18.0 | — | 18.0 | ||||||||||||||
Deferred income taxes | 3.5 | — | 3.5 | ||||||||||||||
Operating lease right-of-use assets | 28.4 | — | 28.4 | ||||||||||||||
Total assets | $ | 3,806.4 | $ | 4.0 | $ | 3,810.4 | |||||||||||
Accounts payable | 17.1 | — | 17.1 | ||||||||||||||
Accrued expenses and other current liabilities | 136.8 | (3.7) | 133.1 | ||||||||||||||
Current portion of long-term debt | 1.1 | — | 1.1 | ||||||||||||||
Current portion of deferred revenue | 335.2 | — | 335.2 | ||||||||||||||
Current portion of operating lease liabilities | 8.0 | — | 8.0 | ||||||||||||||
Long-term debt | 33.4 | — | 33.4 | ||||||||||||||
Deferred income taxes | 58.6 | 0.3 | 58.9 | ||||||||||||||
Non-current portion of deferred revenue | 6.8 | — | 6.8 | ||||||||||||||
Other non-current liabilities | 89.2 | 2.1 | 91.3 | ||||||||||||||
Operating lease liabilities | 23.1 | — | 23.1 | ||||||||||||||
Total liabilities | 709.3 | (1.3) | 708.0 | ||||||||||||||
Fair value of acquired identifiable assets and liabilities | $ | 3,097.1 | $ | 5.3 | $ | 3,102.4 | |||||||||||
Purchase price, net of cash | $ | 4,994.3 | $ | 8.0 | $ | 5,002.3 | |||||||||||
Less: Fair value of acquired identifiable assets and liabilities | 3,097.1 | 5.3 | 3,102.4 | ||||||||||||||
Goodwill | $ | 1,897.2 | $ | 2.7 | $ | 1,899.9 | |||||||||||
(1) Of the $3,534.7, $3,528.0 relates to the valued intangible assets as per the purchase price allocation and $6.7 relates to acquired assets under construction. |
Fair Value as of December 1, 2021 | Remaining Range of Years | ||||||||||
Customer relationships | $ | 2,773.0 | 17-23 | ||||||||
Technology & databases | 709.3 | 5-17 | |||||||||
Trade names | 45.7 | 2-10 | |||||||||
Total identifiable intangible assets | $ | 3,528.0 |
Three Months Ended June 30, | |||||
2021 | |||||
Pro forma revenues, net | $ | 681.1 | |||
Pro forma net loss attributable to the Company's shareholders | (146.0) | ||||
Six Months Ended June 30, | |||||
2021 | |||||
Pro forma revenues, net | $ | 1,329.2 | |||
Pro forma net loss attributable to the Company's shareholders | (217.8) |
June 30, | December 31, | ||||||||||
2022 | 2021 | ||||||||||
Computer hardware | $ | 48.2 | $ | 45.5 | |||||||
Leasehold improvements | 16.3 | 11.6 | |||||||||
Furniture, fixtures and equipment | 37.9 | 34.7 | |||||||||
Capital office leases - finance lease asset | 31.0 | 30.5 | |||||||||
Other | 2.1 | 2.3 | |||||||||
Total property and equipment, gross | 135.5 | 124.6 | |||||||||
Accumulated depreciation | (58.7) | (40.8) | |||||||||
Total property and equipment, net | $ | 76.8 | $ | 83.8 | |||||||
June 30, 2022 | December 31, 2021 | ||||||||||||||||||||||||||||||||||
Gross | Accumulated Amortization | Net | Gross | Accumulated Amortization | Net | ||||||||||||||||||||||||||||||
Finite-lived intangible assets | |||||||||||||||||||||||||||||||||||
Customer relationships | $ | 7,825.3 | $ | (659.4) | $ | 7,165.9 | $ | 8,279.1 | $ | (514.8) | $ | 7,764.3 | |||||||||||||||||||||||
Databases and content | 2,619.2 | (679.6) | 1,939.6 | 2,577.1 | (591.0) | 1,986.1 | |||||||||||||||||||||||||||||
Computer software | 736.1 | (363.2) | 372.9 | 733.1 | (320.1) | 413.0 | |||||||||||||||||||||||||||||
Trade names | 60.8 | (15.4) | 45.4 | 62.1 | (10.5) | 51.6 | |||||||||||||||||||||||||||||
Backlog | 29.0 | (16.8) | 12.2 | 29.1 | (13.0) | 16.1 | |||||||||||||||||||||||||||||
Finite-lived intangible assets | 11,270.4 | (1,734.4) | 9,536.0 | 11,680.5 | (1,449.4) | 10,231.1 | |||||||||||||||||||||||||||||
Indefinite-lived intangible assets | |||||||||||||||||||||||||||||||||||
Trade names | 161.3 | — | 161.3 | 161.3 | — | 161.3 | |||||||||||||||||||||||||||||
Total intangible assets | $ | 11,431.7 | $ | (1,734.4) | $ | 9,697.3 | $ | 11,841.8 | $ | (1,449.4) | $ | 10,392.4 |
Science Segment | Intellectual Property Segment | Consolidated Total | |||||||||||||||
Balance as of December 31, 2021 | $ | 3,326.9 | $ | 4,578.0 | $ | 7,904.9 | |||||||||||
Measurement Period Adjustments(1) | 5.8 | — | 5.8 | ||||||||||||||
Impact of foreign currency fluctuations(2) | (8.7) | (368.3) | (377.0) | ||||||||||||||
Balance as of June 30, 2022 | $ | 3,324.0 | $ | 4,209.7 | $ | 7,533.7 | |||||||||||
(1) Includes $5.8 in purchase accounting adjustments recorded in 2022, of which $2.7 were related to the ProQuest acquisition. See Note 4 - Business Combinations for further information. | |||||||||||||||||
(2) The impact of foreign currency fluctuations was primarily driven by changes in the GBP/USD translation rate as of June 30, 2022 compared to December 31, 2021. Approximately half of the Company's Goodwill and Other intangible assets are denominated in GBP. | |||||||||||||||||
June 30, 2022 | |||||||||||||||||
Level 2 | Level 3 | Total Fair Value | |||||||||||||||
Assets | |||||||||||||||||
Forward currency contracts asset | $ | 0.1 | $ | — | $ | 0.1 | |||||||||||
Interest rate swap asset | 17.9 | — | 17.9 | ||||||||||||||
$ | 18.0 | $ | — | $ | 18.0 | ||||||||||||
Liabilities | |||||||||||||||||
Warrant liability | — | 78.4 | 78.4 | ||||||||||||||
CPA Global Equity Plan liability - current | 9.0 | — | 9.0 | ||||||||||||||
Forward currency contracts liability | 4.3 | — | 4.3 | ||||||||||||||
Total | $ | 13.3 | $ | 78.4 | $ | 91.7 |
December 31, 2021 | |||||||||||||||||
Level 2 | Level 3 | Total Fair Value | |||||||||||||||
Assets | |||||||||||||||||
Forward currency contracts asset | $ | 2.2 | $ | — | $ | 2.2 | |||||||||||
Interest rate swap asset | 2.0 | 2.0 | |||||||||||||||
$ | 4.2 | $ | — | $ | 4.2 | ||||||||||||
Liabilities | |||||||||||||||||
Warrant liability | — | 227.8 | 227.8 | ||||||||||||||
CPA Global Equity Plan liability - current | 152.4 | — | 152.4 | ||||||||||||||
Forward currency contracts liability | 0.7 | — | 0.7 | ||||||||||||||
Total | $ | 153.1 | $ | 227.8 | $ | 380.9 | |||||||||||
Balance at December 31, 2021 | $ | 227.8 | |||
Mark to market gain on financial instruments | (100.4) | ||||
Exercise of Private Placement Warrants | — | ||||
Balance at March 31, 2022 | $ | 127.4 | |||
Mark to market gain on financial instruments | (49.0) | ||||
Exercise of Private Warrants | — | ||||
Balance at June 30, 2022 | $ | 78.4 | |||
Balance at December 31, 2020 | $ | 312.8 | |||
Mark to market gain on financial instruments | (51.2) | ||||
Exercise of Private Placement Warrants | (3.6) | ||||
Balance at March 31, 2021 | $ | 258.0 | |||
Mark to market loss on financial instruments | 21.0 | ||||
Exercise of Private Warrants | — | ||||
Balance at June 30, 2021 | $ | 279.0 | |||
June 30, | December 31, | ||||||||||
2022 | 2021 | ||||||||||
CPA Global Equity Plan liability(1) | $ | 9.0 | $ | 152.4 | |||||||
Employee related accruals(2) | 113.6 | 150.6 | |||||||||
Accrued professional fees(3) | 40.7 | 39.4 | |||||||||
Accrued legal liability(4) | 67.9 | 79.0 | |||||||||
Tax related accruals(5) | 39.5 | 28.5 | |||||||||
Accrued royalty costs(6) | 66.0 | 71.3 | |||||||||
Other accrued expenses and other current liabilities(7) | 164.4 | 158.4 | |||||||||
Total accrued expenses and other current liabilities | $ | 501.1 | $ | 679.6 | |||||||
(1) See Note 9 - Fair Value Measurements and Note 14 - Share-based Compensation for further information. | |||||||||||
(2) Employee related accruals include accrued payroll, bonus and employee commissions. | |||||||||||
(3) Professional and outside service-related fees include accrued legal fees, audit fees, outside services, technology, and contractor fees. | |||||||||||
(4) Of the balance as of June 30, 2022 and December 31, 2021, management estimated the Company's potential liability for the larger legal claims is $60.4 and $60.5, respectively, which includes estimated legal costs and accrued interest. See Note 19 - Commitments and Contingencies for further information with respect to the probable claim reserves. | |||||||||||
(5) Tax related accruals include value-added taxes payable and other current taxes payable. | |||||||||||
(6) Represents accrued royalty costs associated with licensee agreements. | |||||||||||
(7) Includes current liabilities due to customers, interest payable, and miscellaneous other current liabilities. As of June 30, 2022 and December 31, 2021, we recognized $6.2 and $6.5, respectively of accrued preferred share dividends. |
June 30, 2022 | December 31, 2021 | |||||||||||||||||||||||||||||||
Type | Maturity | Effective Interest Rate | Carrying Value | Effective Interest Rate | Carrying Value | |||||||||||||||||||||||||||
Senior Notes | 2029 | 4.875 | % | $ | 921.4 | 4.875 | % | $ | 921.4 | |||||||||||||||||||||||
Senior Secured Notes | 2028 | 3.875 | % | 921.2 | 3.875 | % | 921.2 | |||||||||||||||||||||||||
Revolving Credit Facility | 2027 | 4.375 | % | 175.0 | 3.359 | % | 175.0 | |||||||||||||||||||||||||
Term Loan Facility | 2026 | 4.666 | % | 2,804.5 | 3.860 | % | 2,818.8 | |||||||||||||||||||||||||
Senior Secured Notes | 2026 | 4.500 | % | 700.0 | 4.500 | % | 700.0 | |||||||||||||||||||||||||
Finance lease(1) | 2023 | 3.800 | % | 29.8 | 3.800 | % | 30.8 | |||||||||||||||||||||||||
Total debt outstanding | 5,551.9 | 5,567.2 | ||||||||||||||||||||||||||||||
Debt issuance costs | (42.7) | (47.1) | ||||||||||||||||||||||||||||||
Term Loan Facility (2026), Senior Notes (2029), Senior Secured Notes (2028), discounts | (30.6) | (33.2) | ||||||||||||||||||||||||||||||
Short-term debt, including current portion of Long-term debt | (57.1) | (30.6) | ||||||||||||||||||||||||||||||
Long-term debt, net of current portion and debt issuance costs | $ | 5,421.5 | $ | 5,456.3 | ||||||||||||||||||||||||||||
(1) See Note 5 - Leases for additional information. |
Accounts receivable, net | Current portion of deferred revenues | Non-current portion of deferred revenues | |||||||||||||||
Opening (January 1, 2022) | $ | 906.4 | $ | 1,030.4 | $ | 54.2 | |||||||||||
Closing (June 30, 2022) | 812.4 | 956.7 | 50.3 | ||||||||||||||
Decrease / (increase) | $ | 94.0 | $ | 73.7 | $ | 3.9 | |||||||||||
Opening (January 1, 2021) | $ | 737.7 | $ | 707.3 | $ | 41.4 | |||||||||||
Closing (June 30, 2021) | 628.1 | 664.9 | 48.1 | ||||||||||||||
Decrease / (increase) | $ | 109.6 | $ | 42.4 | $ | (6.7) | |||||||||||
Six Months Ended June 30, | |||||
(in millions) | 2022 | ||||
Total number of shares repurchased | 10.7 | ||||
Average price paid per share | $ | 16.33 | |||
Total | $ | 175.0 | |||
Total shares retired | 10.7 | ||||
Average price paid per share | $ | 16.33 | |||
Total | $ | 175.0 | |||
Three Months Ended June 30, 2022 | |||||||||||||||||||||||||||||
Stock Options | RSUs | PSUs | CPA Global Equity Plan | Total | |||||||||||||||||||||||||
Cost of revenues | $ | — | $ | 7.5 | $ | 0.1 | $ | (0.2) | $ | 7.4 | |||||||||||||||||||
Selling, general and administrative costs | — | 12.6 | 0.9 | 0.8 | 14.3 | ||||||||||||||||||||||||
Total share-based compensation expense | $ | — | $ | 20.1 | $ | 1.0 | $ | 0.6 | $ | 21.7 | |||||||||||||||||||
Six Months Ended June 30, 2022 | |||||||||||||||||||||||||||||
Stock Options | RSUs | PSUs | CPA Global Equity Plan | Total | |||||||||||||||||||||||||
Cost of revenues | $ | — | $ | 17.1 | $ | 0.3 | $ | (0.6) | $ | 16.8 | |||||||||||||||||||
Selling, general and administrative costs | — | 28.8 | 1.9 | 0.9 | 31.6 | ||||||||||||||||||||||||
Total share-based compensation expense | $ | — | $ | 45.9 | $ | 2.2 | $ | 0.3 | $ | 48.4 |
Three Months Ended June 30, 2021 | |||||||||||||||||||||||||||||
Stock Options | RSUs | PSUs | CPA Global Equity Plan | Total | |||||||||||||||||||||||||
Cost of revenues | $ | 0.1 | $ | 4.4 | $ | 0.2 | $ | 13.1 | $ | 17.8 | |||||||||||||||||||
Selling, general and administrative costs | 0.4 | 9.6 | 1.2 | 29.2 | 40.4 | ||||||||||||||||||||||||
Total share-based compensation expense | $ | 0.5 | $ | 14.0 | $ | 1.4 | $ | 42.3 | $ | 58.2 | |||||||||||||||||||
Six months ended June 30, 2021 | |||||||||||||||||||||||||||||
Stock Options | RSUs | PSUs | CPA Global Equity Plan | Total | |||||||||||||||||||||||||
Cost of revenues | $ | 0.1 | $ | 8.2 | $ | 0.3 | $ | 22.2 | $ | 30.8 | |||||||||||||||||||
Selling, general and administrative costs | 0.4 | 15.2 | 2.4 | 48.4 | 66.4 | ||||||||||||||||||||||||
Total share-based compensation expense | $ | 0.5 | $ | 23.4 | $ | 2.7 | $ | 70.6 | $ | 97.2 |
Six Months Ended June 30, 2022 | |||||||||||||||||
Stock Options | RSUs | PSUs | |||||||||||||||
Balance at December 31, 2021 | 4.8 | 4.5 | 1.4 | ||||||||||||||
Granted | — | 4.5 | 0.9 | ||||||||||||||
Exercised/Vested | (0.2) | (2.0) | — | ||||||||||||||
Forfeited/Unexercised | (0.1) | (0.4) | (0.1) | ||||||||||||||
Balance at June 30, 2022 | 4.5 | 6.6 | 2.2 | ||||||||||||||
Total remaining unearned compensation costs | — | 72.1 | 9.4 | ||||||||||||||
Weighted average remaining service period | 0 years | 1.43 years | 1.69 years |
Three Months Ended June 30, | |||||||||||
2022 | 2021 | ||||||||||
Basic EPS | |||||||||||
Net income (loss) available to ordinary shareholders | $ | 62.4 | $ | (131.5) | |||||||
Dividends on preferred shares | 18.7 | — | |||||||||
Net income (loss) attributable to ordinary shares | $ | 43.7 | $ | (131.5) | |||||||
Basic weighted-average number of ordinary shares outstanding | 674.3 | 611.1 | |||||||||
Basic EPS | $ | 0.06 | $ | (0.22) | |||||||
Diluted EPS | |||||||||||
Net income (loss) attributable to ordinary shares | $ | 43.7 | $ | (131.5) | |||||||
Change in fair value of private placement warrants | (46.8) | — | |||||||||
Net income (loss) attributable to ordinary shares, diluted | $ | (3.1) | $ | (131.5) | |||||||
Denominator: | |||||||||||
Shares used in computing net income (loss) attributable to per share to ordinary shareholders, basic | 674.3 | 611.1 | |||||||||
Weighted-average effect of potentially dilutive shares to purchase ordinary shares | 4.1 | — | |||||||||
Diluted weighted-average number of ordinary shares outstanding | 678.4 | 611.1 | |||||||||
Diluted EPS | $ | (0.00) | $ | (0.22) | |||||||
Six Months Ended June 30, | |||||||||||
2022 | 2021 | ||||||||||
Basic EPS | |||||||||||
Net income (loss) available to ordinary shareholders | $ | 131.9 | $ | (187.5) | |||||||
Dividends on preferred shares | 37.4 | — | |||||||||
Net income (loss) attributable to ordinary shares | $ | 94.5 | $ | (187.5) | |||||||
Basic weighted-average number of ordinary shares outstanding | 678.3 | 606.8 | |||||||||
Basic EPS | $ | 0.14 | $ | (0.31) | |||||||
Diluted EPS | |||||||||||
Net income (loss) attributable to ordinary shares | $ | 94.5 | $ | (187.5) | |||||||
Change in fair value of private placement warrants | (141.7) | (30.1) | |||||||||
Net income (loss) attributable to ordinary shares, diluted | $ | (47.2) | $ | (217.6) | |||||||
Denominator: | |||||||||||
Shares used in computing net income (loss) attributable to per share to ordinary shareholders, basic | 678.3 | 606.8 | |||||||||
Weighted-average effect of potentially dilutive shares to purchase ordinary shares | 4.9 | 10.3 | |||||||||
Diluted weighted-average number of ordinary shares outstanding | 683.2 | 617.1 | |||||||||
Diluted EPS | $ | (0.07) | $ | (0.35) | |||||||
Three Months Ended June 30, | |||||||||||
2022 | 2021 | ||||||||||
Net foreign exchange (gain) loss | $ | (23.5) | $ | (0.2) | |||||||
Miscellaneous (income) expense, net | (1.1) | (0.7) | |||||||||
Other operating (income) expense, net | $ | (24.6) | $ | (0.9) | |||||||
Six Months Ended June 30, | |||||||||||
2022 | 2021 | ||||||||||
Net foreign exchange (gain) loss | $ | (43.9) | $ | 15.8 | |||||||
Miscellaneous expense (income), net | 5.6 | (0.5) | |||||||||
Other operating (income) expense, net | $ | (38.3) | $ | 15.3 | |||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
Science Segment | $ | 448.2 | $ | 202.3 | $ | 868.6 | $ | 393.6 | |||||||||||||||
Intellectual Property Segment | 238.4 | 243.4 | 480.2 | 480.5 | |||||||||||||||||||
Total Revenues, net | $ | 686.6 | $ | 445.7 | $ | 1,348.8 | $ | 874.1 |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
Science Segment Adjusted EBITDA | $ | 175.2 | $ | 100.7 | $ | 326.4 | $ | 191.3 | ||||||||||||||||||
Intellectual Property Segment Adjusted EBITDA | 99.2 | 88.3 | 210.3 | 162.5 | ||||||||||||||||||||||
Total Adjusted EBITDA | $ | 274.4 | $ | 189.0 | $ | 536.7 | $ | 353.8 | ||||||||||||||||||
Provision for income taxes | (10.5) | (8.2) | (26.8) | (8.5) | ||||||||||||||||||||||
Depreciation and amortization | (175.6) | (130.3) | (352.0) | (261.9) | ||||||||||||||||||||||
Interest expense and amortization of debt discount, net | (62.3) | (38.5) | (121.8) | (75.9) | ||||||||||||||||||||||
Mark to market gain (loss) on financial instruments(1) | 49.0 | (21.0) | 149.4 | 30.2 | ||||||||||||||||||||||
Deferred revenues adjustment(2) | (0.8) | (1.4) | (0.6) | (4.4) | ||||||||||||||||||||||
Transaction related costs(3) | (5.1) | (13.9) | (11.8) | 9.0 | ||||||||||||||||||||||
Share-based compensation expense | (22.1) | (58.2) | (59.1) | (97.2) | ||||||||||||||||||||||
Restructuring and impairment(4) | (19.2) | (50.7) | (30.9) | (118.6) | ||||||||||||||||||||||
Other(5) | 34.6 | 1.7 | 48.8 | (14.0) | ||||||||||||||||||||||
Net income (loss) | $ | 62.4 | $ | (131.5) | $ | 131.9 | $ | (187.5) | ||||||||||||||||||
Dividends on preferred shares | (18.7) | — | (37.4) | — | ||||||||||||||||||||||
Net income (loss) attributable to ordinary shares | $ | 43.7 | $ | (131.5) | $ | 94.5 | $ | (187.5) | ||||||||||||||||||
(1) Reflects mark-to-market adjustments on financial instruments under ASC 815, Derivatives and Hedging. Warrant instruments that do not meet the criteria to be considered indexed to an entity's own stock shall be initially classified as a liability at their estimated fair values, regardless of the likelihood that such instruments will ever be settled in cash. In periods subsequent to issuance, changes in the estimated fair value of the liabilities are reported through earnings. | ||||||||||||||||||||||||||
(2) Reflects the deferred revenues adjustment made as a result of purchase accounting prior to the adoption of ASU No. 2021-08, "Accounting for Contract Assets and Contract Liabilities from Contracts with Customers". In the fourth quarter of 2021, Clarivate adopted ASU No. 2021-08 which allows an acquirer to account for the related revenue contracts in accordance with ASC 606, Revenue from Contracts with Customers, as if it had originated the contracts. This guidance was applied retrospectively to all business combinations for which the acquisition date occurs during or subsequent to 2021. | ||||||||||||||||||||||||||
(3) Includes costs incurred to complete business combination transactions, including acquisitions, dispositions and capital market activities and include advisory, legal, and other professional and consulting costs. During the six months ended June 30, 2021, this also includes the mark-to-market adjustments on the contingent stock consideration associated with the CPA Global and DRG acquisitions. | ||||||||||||||||||||||||||
(4) Primarily reflects costs related to restructuring and impairment associated with One Clarivate, ProQuest and CPA Global Programs. Refer to Note 21 - Restructuring and Impairment for further information. | ||||||||||||||||||||||||||
(5) Includes primarily the net impact of foreign exchange gains and losses related to the re-measurement of balances and other items that do not reflect our ongoing operating performance. |
Restructuring Programs | Severance and Related Benefit Costs | Costs Associated with Exit and Disposal Costs(1) | Total | |||||||||||||||||
Reserve Balance as of December 31, 2021 | $ | 28.3 | $ | 0.7 | $ | 29.0 | ||||||||||||||
Expenses recorded(2) | 10.3 | 1.4 | 11.7 | |||||||||||||||||
Payments made | (23.7) | (0.5) | (24.2) | |||||||||||||||||
Noncash items | (0.1) | 0.5 | 0.4 | |||||||||||||||||
Reserve Balance as of March 31, 2022 | $ | 14.8 | $ | 2.1 | $ | 16.9 | ||||||||||||||
Expenses recorded(2) | 12.1 | 7.1 | 19.2 | |||||||||||||||||
Payments made | (10.9) | (2.2) | (13.1) | |||||||||||||||||
Noncash items | (2.5) | (5.9) | (8.4) | |||||||||||||||||
Reserve Balance as of June 30, 2022 | $ | 13.5 | $ | 1.1 | $ | 14.6 | ||||||||||||||
Reserve Balance as of December 31, 2020 | $ | 25.7 | $ | 3.8 | $ | 29.5 | ||||||||||||||
Expenses recorded(2) | 22.2 | 45.7 | 67.9 | |||||||||||||||||
Payments made | (15.9) | (4.2) | (20.1) | |||||||||||||||||
Noncash items | (1.4) | (40.9) | (42.3) | |||||||||||||||||
Reserve Balance as of March 31, 2021 | $ | 30.6 | $ | 4.4 | $ | 35.0 | ||||||||||||||
Expenses recorded(2) | 26.2 | 24.5 | 50.7 | |||||||||||||||||
Payments made | (10.6) | (22.8) | (33.4) | |||||||||||||||||
Asset Impairment Charge | — | (2.7) | (2.7) | |||||||||||||||||
Reserve Balance as of June 30, 2021 | $ | 46.2 | $ | 3.4 | $ | 49.6 | ||||||||||||||
(1) Relates primarily to lease exit costs and legal and advisory fees. Certain prior period amounts were revised for both the three months ended March 31, 2021 and June 30, 2021 to properly reflect certain cash payments previously omitted or classified as Noncash items. | ||||||||||||||||||||
(2) Expenses include the acceleration of phantom equity awards under the CPA Global Equity Plan that were held by employees whose employment was involuntarily terminated. These expenses will be paid in cash and are accounted for as a liability award. | ||||||||||||||||||||
June 30, 2022 | December 31, 2021 | |||||||||||||
Long-term severance payable | $ | 7.4 | $ | 8.6 |
June 30, | Change(1) | ||||||||||||||||||||||
2022 | 2021 | 2022 vs. 2021 | |||||||||||||||||||||
Annualized Contract Value | $ | 1,625.9 | $ | 924.4 | $ | 701.5 | 75.9 | % | |||||||||||||||
(1) The change in ACV is primarily due to the acquisition of ProQuest in December 2021, supplemented by organic ACV growth of 3.8%. |
Variance Increase/(Decrease) | Percentage of Factors Increase/(Decrease) | ||||||||||||||||||||||||||||
Three Months Ended June 30, | Total Variance (Dollars) | Total Variance (Percentage) | Acquisitions | FX Impact | Organic | ||||||||||||||||||||||||
(in millions, except percentages) | 2022 | 2021(1) | |||||||||||||||||||||||||||
Subscription revenues | $ | 407.4 | $ | 243.4 | $ | 164.0 | 67.4 | % | 68.9 | % | (5.4) | % | 3.8 | % | |||||||||||||||
Re-occurring revenues | 112.0 | 113.7 | (1.7) | (1.5) | % | — | % | (8.2) | % | 6.7 | % | ||||||||||||||||||
Transactional and other revenues | 168.0 | 90.0 | 78.0 | 86.7 | % | 85.6 | % | (3.9) | % | 5.0 | % | ||||||||||||||||||
Deferred revenues adjustment(2) | (0.8) | (1.4) | 0.6 | 42.9 | % | (42.9) | % | — | % | — | % | ||||||||||||||||||
Revenues, net | $ | 686.6 | $ | 445.7 | $ | 240.9 | 54.0 | % | 55.1 | % | (5.8) | % | 4.8 | % | |||||||||||||||
(1) Certain prior period amounts have been reclassified to conform to current period presentation. | |||||||||||||||||||||||||||||
(2) Reflects the deferred revenues adjustment made as a result of purchase accounting prior to the adoption of ASU No. 2021-08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. In the fourth quarter of 2021, Clarivate adopted ASU No. 2021-08 which allows an acquirer to account for the related revenue contracts in accordance with ASC 606 Revenue from Contracts with Customers, as if it had originated the contracts. This guidance was applied retrospectively to all business combinations for which the acquisition date occurs during or subsequent to 2021. | |||||||||||||||||||||||||||||
Variance Increase/(Decrease) | Percentage of Factors Increase/(Decrease) | ||||||||||||||||||||||||||||
Six Months Ended June 30, | Total Variance (Dollars) | Total Variance (Percentage) | Acquisitions | FX Impact | Organic | ||||||||||||||||||||||||
(in millions, except percentages) | 2022 | 2021(1) | |||||||||||||||||||||||||||
Subscription revenues | $ | 811.2 | $ | 482.4 | $ | 328.8 | 68.2 | % | 68.8 | % | (4.0) | % | 3.3 | % | |||||||||||||||
Re-occurring revenues | 226.5 | 223.2 | 3.3 | 1.5 | % | — | % | (6.5) | % | 8.0 | % | ||||||||||||||||||
Transactional and other revenues | 311.7 | 172.9 | 138.8 | 80.3 | % | 79.7 | % | (3.1) | % | 3.7 | % | ||||||||||||||||||
Deferred revenues adjustment(2) | (0.6) | (4.4) | 3.8 | 86.4 | % | (86.4) | % | — | % | — | % | ||||||||||||||||||
Revenues, net | $ | 1,348.8 | $ | 874.1 | $ | 474.7 | 54.3 | % | 54.2 | % | (4.5) | % | 4.6 | % | |||||||||||||||
(1) Certain prior period amounts have been reclassified to conform to current period presentation. | |||||||||||||||||||||||||||||
(2) Reflects the deferred revenues adjustment made as a result of purchase accounting prior to the adoption of ASU No. 2021-08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. In the fourth quarter of 2021, Clarivate adopted ASU No. 2021-08 which allows an acquirer to account for the related revenue contracts in accordance with ASC 606 Revenue from Contracts with Customers, as if it had originated the contracts. This guidance was applied retrospectively to all business combinations for which the acquisition date occurs during or subsequent to 2021. | |||||||||||||||||||||||||||||
Variance Increase/(Decrease) | Percentage of Factors Increase/(Decrease) | ||||||||||||||||||||||||||||
Three Months Ended June 30, | Total Variance (Dollars) | Total Variance (Percentage) | Acquisitions | FX Impact | Organic | ||||||||||||||||||||||||
(in millions, except percentages) | 2022 | 2021 | |||||||||||||||||||||||||||
Americas | $ | 384.5 | $ | 221.4 | $ | 163.1 | 73.7 | % | 71.8 | % | (2.2) | % | 4.0 | % | |||||||||||||||
Europe/Middle East/Africa | 178.6 | 133.5 | 45.1 | 33.8 | % | 41.0 | % | (9.3) | % | 2.0 | % | ||||||||||||||||||
Asia Pacific | 124.3 | 92.2 | 32.1 | 34.8 | % | 33.6 | % | (9.4) | % | 10.6 | % | ||||||||||||||||||
Deferred revenues adjustment(1) | (0.8) | (1.4) | 0.6 | 42.9 | % | (42.9) | % | — | % | — | % | ||||||||||||||||||
Revenues, net | $ | 686.6 | $ | 445.7 | $ | 240.9 | 54.0 | % | 55.1 | % | (5.8) | % | 4.8 | % | |||||||||||||||
(1) Reflects the deferred revenues adjustment made as a result of purchase accounting prior to the adoption of ASU No. 2021-08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. In the fourth quarter of 2021, Clarivate adopted ASU No. 2021-08 which allows an acquirer to account for the related revenue contracts in accordance with ASC 606 Revenue from Contracts with Customers, as if it had originated the contracts. This guidance was applied retrospectively to all business combinations for which the acquisition date occurs during or subsequent to 2021. | |||||||||||||||||||||||||||||
Variance Increase/(Decrease) | Percentage of Factors Increase/(Decrease) | ||||||||||||||||||||||||||||
Six Months Ended June 30, | Total Variance (Dollars) | Total Variance (Percentage) | Acquisitions | FX Impact | Organic | ||||||||||||||||||||||||
(in millions, except percentages) | 2022 | 2021 | |||||||||||||||||||||||||||
Americas | $ | 744.8 | $ | 424.6 | $ | 320.2 | 75.4 | % | 70.7 | % | (1.8) | % | 6.5 | % | |||||||||||||||
Europe/Middle East/Africa | 356.1 | 265.6 | 90.5 | 34.1 | % | 40.8 | % | (7.0) | % | 0.3 | % | ||||||||||||||||||
Asia Pacific | 248.5 | 188.3 | 60.2 | 32.0 | % | 32.6 | % | (6.9) | % | 6.3 | % | ||||||||||||||||||
Deferred revenues adjustment(1) | (0.6) | (4.4) | 3.8 | 86.4 | % | (86.4) | % | — | % | — | % | ||||||||||||||||||
Revenues, net | $ | 1,348.8 | $ | 874.1 | $ | 474.7 | 54.3 | % | 54.2 | % | (4.5) | % | 4.6 | % | |||||||||||||||
(1) Reflects the deferred revenues adjustment made as a result of purchase accounting prior to the adoption of ASU No. 2021-08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. In the fourth quarter of 2021, Clarivate adopted ASU No. 2021-08 which allows an acquirer to account for the related revenue contracts in accordance with ASC 606 Revenue from Contracts with Customers, as if it had originated the contracts. This guidance was applied retrospectively to all business combinations for which the acquisition date occurs during or subsequent to 2021. |
Variance Increase/(Decrease) | Percentage of Factors Increase/(Decrease) | ||||||||||||||||||||||||||||
Three Months Ended June 30, | Total Variance (Dollars) | Total Variance (Percentage) | Acquisitions | FX Impact | Organic | ||||||||||||||||||||||||
(in millions, except percentages) | 2022 | 2021 | |||||||||||||||||||||||||||
Science Segment | $ | 448.2 | $ | 202.3 | $ | 245.9 | 121.6 | % | 121.0 | % | (4.9) | % | 5.5 | % | |||||||||||||||
IP Segment | $ | 239.2 | $ | 244.8 | $ | (5.6) | (2.3) | % | — | % | (6.5) | % | 4.2 | % | |||||||||||||||
Deferred revenues adjustment(1) | $ | (0.8) | $ | (1.4) | $ | 0.6 | 42.9 | % | (42.9) | % | — | % | — | % | |||||||||||||||
Revenues, net | $ | 686.6 | $ | 445.7 | $ | 240.9 | 54.0 | % | 55.1 | % | (5.8) | % | 4.8 | % | |||||||||||||||
(1) Reflects the deferred revenues adjustment made as a result of purchase accounting prior to the adoption of ASU No. 2021-08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. In the fourth quarter of 2021, Clarivate adopted ASU No. 2021-08 which allows an acquirer to account for the related revenue contracts in accordance with ASC 606 Revenue from Contracts with Customers, as if it had originated the contracts. This guidance was applied retrospectively to all business combinations for which the acquisition date occurs during or subsequent to 2021. | |||||||||||||||||||||||||||||
Variance Increase/(Decrease) | Percentage of Factors Increase/(Decrease) | ||||||||||||||||||||||||||||
Six Months Ended June 30, | Total Variance (Dollars) | Total Variance (Percentage) | Acquisitions | FX Impact | Organic | ||||||||||||||||||||||||
(in millions, except percentages) | 2022 | 2021 | |||||||||||||||||||||||||||
Science Segment | $ | 868.6 | $ | 393.6 | $ | 475.0 | 120.7 | % | 119.4 | % | (3.7) | % | 5.0 | % | |||||||||||||||
IP Segment | 480.8 | 484.9 | (4.1) | (0.8) | % | — | % | (5.1) | % | 4.2 | % | ||||||||||||||||||
Deferred revenues adjustment(1) | (0.6) | (4.4) | 3.8 | 86.4 | % | (86.4) | % | — | % | — | % | ||||||||||||||||||
Revenues, net | $ | 1,348.8 | $ | 874.1 | $ | 474.7 | 54.3 | % | 54.2 | % | (4.5) | % | 4.6 | % | |||||||||||||||
(1) Reflects the deferred revenues adjustment made as a result of purchase accounting prior to the adoption of ASU No. 2021-08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. In the fourth quarter of 2021, Clarivate adopted ASU No. 2021-08 which allows an acquirer to account for the related revenue contracts in accordance with ASC 606 Revenue from Contracts with Customers, as if it had originated the contracts. This guidance was applied retrospectively to all business combinations for which the acquisition date occurs during or subsequent to 2021. |
Three Months Ended June 30, | Change 2022 vs. 2021 | Six Months Ended June 30, | Change 2022 vs. 2021 | ||||||||||||||||||||||||||||||||||||||||||||
(in millions, except percentages) | 2022 | 2021 | $ | % | 2022 | 2021 | $ | % | |||||||||||||||||||||||||||||||||||||||
Operating Expenses: | |||||||||||||||||||||||||||||||||||||||||||||||
Cost of revenues | $ | 244.1 | $ | 149.7 | $ | 94.4 | 63.1 | % | $ | 493.3 | $ | 297.6 | $ | 195.7 | 65.8 | % | |||||||||||||||||||||||||||||||
Selling, general and administrative costs | 186.1 | 179.7 | 6.4 | 3.6 | % | 379.8 | 314.0 | 65.8 | 21.0 | % | |||||||||||||||||||||||||||||||||||||
Total cost of revenues and selling, general and administrative costs | $ | 430.2 | $ | 329.4 | $ | 100.8 | 30.6 | % | $ | 873.1 | $ | 611.6 | $ | 261.5 | 42.8 | % | |||||||||||||||||||||||||||||||
Depreciation and amortization expense | $ | 175.6 | $ | 130.3 | $ | 45.3 | 34.8 | % | $ | 352.0 | $ | 261.9 | $ | 90.1 | 34.4 | % | |||||||||||||||||||||||||||||||
As a percentage of revenue: | |||||||||||||||||||||||||||||||||||||||||||||||
Total cost of revenues and selling, general and administrative costs | 62.7 | % | 73.9 | % | 64.7 | % | 70.0 | % | |||||||||||||||||||||||||||||||||||||||
Depreciation and amortization expense | 25.6 | % | 29.2 | % | 26.1 | % | 30.0 | % |
Three Months Ended June 30, | Change 2022 vs. 2021 | Six Months Ended June 30, | Change 2022 vs. 2021 | ||||||||||||||||||||||||||||||||||||||||||||
2022 | 2021 | $ | % | 2022 | 2021 | $ | % | ||||||||||||||||||||||||||||||||||||||||
Restructuring and impairment | $ | 19.2 | $ | 50.7 | $ | (31.5) | (62.1) | % | $ | 30.9 | $ | 118.6 | $ | (87.7) | (73.9) | % |
Total Costs Incurred to Date | Costs Expected to be Incurred in Future Periods | ||||||||||
One Clarivate Program | $ | 31.2 | $ | 5.0 | |||||||
ProQuest Acquisition Integration Program | 22.1 | 30.0 | |||||||||
Other Restructuring Programs: | |||||||||||
CPA Global Acquisition Integration and Optimization Program | 127.7 | — | |||||||||
DRG Acquisition Integration Program | 6.7 | — | |||||||||
Operation Simplification and Optimization Program | 44.5 | — | |||||||||
Total Other Restructuring Programs | $ | 178.9 | $ | — |
Three Months Ended June 30, | Change 2022 vs. 2021 | Six Months Ended June 30, | Change 2022 vs. 2021 | ||||||||||||||||||||||||||||||||||||||||||||
2022 | 2021 | $ | % | 2022 | 2021 | $ | % | ||||||||||||||||||||||||||||||||||||||||
Other operating (income) expense, net | $ | (24.6) | $ | (0.9) | $ | 23.7 | 2,633.3 | % | $ | (38.3) | $ | 15.3 | $53.6 | 350.3 | % |
Three Months Ended June 30, | Change 2022 vs. 2021 | Six Months Ended June 30, | Change 2022 vs. 2021 | ||||||||||||||||||||||||||||||||||||||||||||
2022 | 2021 | $ | % | 2022 | 2021 | $ | % | ||||||||||||||||||||||||||||||||||||||||
Mark to market (gain) loss on financial instruments | $ | (49.0) | $ | 21.0 | $ | 70.0 | 333.3 | % | $(149.4) | $(30.2) | $119.2 | 394.7 | % |
Three Months Ended June 30, | Change 2022 vs. 2021 | Six Months Ended June 30, | Change 2022 vs. 2021 | ||||||||||||||||||||||||||||||||||||||||||||
2022 | 2021 | $ | % | 2022 | 2021 | $ | % | ||||||||||||||||||||||||||||||||||||||||
Interest expense and amortization of debt discount, net | $ | 62.3 | $ | 38.5 | $ | 23.8 | 61.8 | % | $ | 121.8 | $ | 75.9 | $45.9 | 60.5 | % |
Three Months Ended June 30, | Change 2022 vs. 2021 | Six Months Ended June 30, | Change 2022 vs. 2021 | ||||||||||||||||||||||||||||||||||||||||||||
2022 | 2021 | $ | % | 2022 | 2021 | $ | % | ||||||||||||||||||||||||||||||||||||||||
Dividends on preferred shares | $ | 18.7 | $ | — | $ | 18.7 | 100.0 | % | $ | 37.4 | $ | — | $37.4 | 100.0 | % |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
(in millions, except percentages) | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
Net income (loss) attributable to ordinary shares | $ | 43.7 | $ | (131.5) | $ | 94.5 | $ | (187.5) | |||||||||||||||
Dividends on preferred shares | 18.7 | — | 37.4 | — | |||||||||||||||||||
Net income (loss) | 62.4 | (131.5) | 131.9 | (187.5) | |||||||||||||||||||
Provision for income taxes | 10.5 | 8.2 | 26.8 | 8.5 | |||||||||||||||||||
Depreciation and amortization | 175.6 | 130.3 | 352.0 | 261.9 | |||||||||||||||||||
Interest expense and amortization of debt discount, net | 62.3 | 38.5 | 121.8 | 75.9 | |||||||||||||||||||
Deferred revenues adjustment(1) | 0.8 | 1.4 | 0.6 | 4.4 | |||||||||||||||||||
Transaction related costs(2) | 5.1 | 13.9 | 11.8 | (9.0) | |||||||||||||||||||
Share-based compensation expense | 22.1 | 58.2 | 59.1 | 97.2 | |||||||||||||||||||
Restructuring and impairment(3) | 19.2 | 50.7 | 30.9 | 118.6 | |||||||||||||||||||
Mark to market (gain) loss on financial instruments(4) | (49.0) | 21.0 | (149.4) | (30.2) | |||||||||||||||||||
Other(5) | (34.6) | (1.7) | (48.8) | 14.0 | |||||||||||||||||||
Adjusted EBITDA | $ | 274.4 | $ | 189.0 | $ | 536.7 | $ | 353.8 | |||||||||||||||
Adjusted EBITDA margin | 39.9% | 42.3% | 39.8% | 40.3% | |||||||||||||||||||
(1) Reflects the deferred revenues adjustment made as a result of purchase accounting prior to the adoption of ASU No. 2021-08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. In the fourth quarter of 2021, Clarivate adopted ASU No. 2021-08 which allows an acquirer to account for the related revenue contracts in accordance with ASC 606, Revenue from Contracts with Customers, as if it had originated the contracts. This guidance was applied retrospectively to all business combinations for which the acquisition date occurs during or subsequent to 2021. | |||||||||||||||||||||||
(2) Includes costs incurred to complete business combination transactions, including acquisitions, dispositions and capital market activities and include advisory, legal, and other professional and consulting costs. During the six months ended June 30, 2021, this also includes the mark-to-market adjustments on the contingent stock consideration associated with the CPA Global and DRG acquisitions. | |||||||||||||||||||||||
(3) Primarily reflects costs related to restructuring and impairment associated with One Clarivate, ProQuest and CPA Global Programs. Refer to Note 21 - Restructuring and Impairment in Item 1, Financial Statements and Supplementary Data, for further information. | |||||||||||||||||||||||
(4) Reflects mark-to-market adjustments on financial instruments under ASC 815, Derivatives and Hedging. Warrant instruments that do not meet the criteria to be considered indexed to an entity's own stock shall be initially classified as a liability at their estimated fair values, regardless of the likelihood that such instruments will ever be settled in cash. In periods subsequent to issuance, changes in the estimated fair value of the liabilities are reported through earnings. | |||||||||||||||||||||||
(5) Primarily includes the net impact of foreign exchange gains and losses related to the re-measurement of balances and other items that do not reflect our ongoing operating performance. |
Total Liquidity | June 30, | December 31, | |||||||||
(in millions) | 2022 | 2021 | |||||||||
Cash and cash equivalents | $ | 359.7 | $ | 430.9 | |||||||
Additional availability under revolving credit facility | 568.7 | 168.9 | |||||||||
$ | 928.4 | $ | 599.8 |
Six Months Ended June 30, | |||||||||||
2022 | 2021 | ||||||||||
Net cash provided by operating activities | $ | 164.6 | $ | 261.7 | |||||||
Net cash used in investing activities | (103.4) | (61.6) | |||||||||
Net cash (used in) provided by financing activities | (239.4) | 4,096.4 | |||||||||
Effect of exchange rates | (36.5) | 5.0 | |||||||||
Net (decrease) increase in cash and cash equivalents, and restricted cash | $ | (214.7) | $ | 4,301.5 | |||||||
Net (decrease) increase in cash and cash equivalents | $ | (71.2) | $ | 2,301.9 | |||||||
Net (decrease) increase in restricted cash | (143.5) | 1,999.6 | |||||||||
Net (decrease) increase in cash and cash equivalents, and restricted cash | $ | (214.7) | $ | 4,301.5 | |||||||
Cash and cash equivalents, beginning of period | $ | 430.9 | $ | 257.7 | |||||||
Restricted cash, beginning of period | 156.7 | 14.7 | |||||||||
Cash and cash equivalents, and restricted cash beginning of the year | $ | 587.6 | $ | 272.4 | |||||||
Cash and cash equivalents, end of period | $ | 359.7 | $ | 2,559.6 | |||||||
Restricted cash, end of period | 13.2 | 2,014.3 | |||||||||
Cash and cash equivalents, and restricted cash end of the period | $ | 372.9 | $ | 4,573.9 | |||||||
Net Working Capital | |||||||||||||||||||||||
June 30, 2022 | December 31, 2021 | June 30, 2021 | December 31, 2020 | ||||||||||||||||||||
Current assets | $ | 1,360.2 | $ | 1,637.2 | $ | 5,316.4 | $ | 1,147.6 | |||||||||||||||
Current liabilities | 1,661.5 | 1,902.0 | 3,360.6 | 1,423.1 | |||||||||||||||||||
Net Working Capital | $ | (301.3) | $ | (264.8) | $ | 1,955.8 | $ | (275.5) |
Six Months Ended June 30, | |||||||||||
2022 | 2021 | ||||||||||
Net cash provided by operating activities | $ | 164.6 | $ | 261.7 | |||||||
Capital expenditures | (89.1) | (62.0) | |||||||||
Free cash flow | $ | 75.5 | $ | 199.7 | |||||||
Cash paid for CPA Global equity plan(1) | 150.7 | — | |||||||||
Cash paid for restructuring costs(2) | 21.7 | 48.7 | |||||||||
Cash paid for transaction related costs(3) | 7.9 | 8.8 | |||||||||
Cash paid for other costs(4) | 2.3 | 1.3 | |||||||||
Adjusted free cash flow | $ | 258.1 | $ | 258.5 | |||||||
(1) Includes cash funded by a trust related to CPA Global equity plan payout upon vesting. | |||||||||||
(2) Reflects cash payments for costs primarily related to restructuring and lease-exit activities associated with the One Clarivate, ProQuest and CPA Global Programs. The costs associated with the CPA Global program were substantially complete as of June 30, 2022. | |||||||||||
(3) Includes cash paid for costs incurred to complete business combination transactions, which comprises of acquisitions, dispositions and capital market activities, as well as advisory, legal, and other professional and consulting costs. | |||||||||||
(4) Includes cash paid for other costs that do not reflect our ongoing operating performance. |
Rate for 1 USD | Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||||||||||||||||
Currency: | 2022 | 2021 | Percentage Change | 2022 | 2021 | Percentage Change | ||||||||||||||||||||||||||||||||
GBP | $ | 0.80 | $ | 0.72 | 11 | % | $ | 0.77 | $ | 0.72 | 7 | % | ||||||||||||||||||||||||||
EUR | 0.94 | 0.83 | 13 | % | 0.92 | 0.83 | 11 | % | ||||||||||||||||||||||||||||||
JPY | 129.66 | 109.46 | 18 | % | 123.02 | 107.71 | 14 | % |
Period | Total Number of Shares Purchased(1) | Price Paid Per Share | Total Number of Shares Purchased As Part of Publicly Announced Plans or Programs | Approx. Dollar value of shares that may Yet Be Purchased Under Plans or Programs | ||||||||||||||||||||||
January 1, 2022-January 31, 2022 | 9,580 | $ | 18.00 | — | $ | — | ||||||||||||||||||||
February 1, 2022-February 28, 2022 | 7,825 | $ | 16.78 | — | $ | 1,000 | ||||||||||||||||||||
March 1, 2022-March 31, 2022 | 4,559,871 | $ | 16.10 | 4,106,285 | $ | 934 | ||||||||||||||||||||
April 1, 2022-April 30, 2022 | 6,718,312 | $ | 16.44 | 6,611,994 | $ | 825 | ||||||||||||||||||||
May 1, 2022-May 31, 2022 | 257,078 | $ | 14.36 | $ | 825 | |||||||||||||||||||||
June 1, 2022-June 30, 2022 | 20,413 | $ | 13.51 | — | $ | 825 | ||||||||||||||||||||
Total | 11,573,079 | $ | 16.26 | 10,718,279 | ||||||||||||||||||||||
(1) Includes shares withheld to satisfy tax withholding obligations on behalf of employees that occur upon vesting and delivery of outstanding shares underlying stock options and restricted stock units under the 2019 Incentive Award Plan. |
10.1* | |||||
10.2* | |||||
31* | |||||
32* | |||||
101* | The following information from our Form 10-Q for the quarterly period ended June 30, 2022, formatted in Inline eXtensible Business Reporting Language: (i) Condensed Consolidated Statements of Comprehensive Income (unaudited), (ii) Condensed Consolidated Balance Sheets (unaudited), (iii) Condensed Consolidated Statements of Changes in Equity (unaudited), (iv) Condensed Consolidated Statements of Cash Flows (unaudited), and (v) the Notes to the Condensed Consolidated Financial Statements (unaudited). | ||||
104* | The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2022, formatted in Inline XBRL |
CLARIVATE PLC | |||||
By: | /s/ Jonathan M. Collins | ||||
Name: Jonathan M. Collins | |||||
Title: Executive Vice President & Chief Financial Officer |
DATED 25 MAY 2022 | ||||||||
(1)CPA LIMITED (2)GORDON SAMSON | ||||||||
SERVICE AGREEMENT | ||||||||
/s/ Jerre Stead | ||
Jerre Stead Executive Chairman and Chief Executive Officer For and on behalf of CPA Limited | ||
/s/ Gordon Samson | ||
Gordon Samson | ||
/s/ Nicola Maynard | ||
Witnessed by Nicola Maynard |
Date: August 9, 2022 | /s/ Jerre Stead | ||||
Jerre Stead | |||||
Executive Chairman and Chief Executive Officer |
Date: August 9, 2022 | /s/ Jonathan M. Collins | ||||
Jonathan M. Collins | |||||
Executive Vice President and Chief Financial Officer |
Date: August 9, 2022 | /s/ Jerre Stead | ||||
Jerre Stead | |||||
Executive Chairman and Chief Executive Officer |
Date: August 9, 2022 | /s/ Jonathan M. Collins | ||||
Jonathan M. Collins | |||||
Executive Vice President and Chief Financial Officer |